Digital channels for collecting data on adverse drug events
Елена Матвеева2021-06-20T17:12:06+03:00Following the rules of good practice for pharmacovigilance of the Eurasian Economic Union, one of the processes for documenting the critical process of working with HP at the manufacturer of medicinal products, which should be reflected in the Master File of the FN System (MFSF) - the main document of the pharmacovigilance system, is the [...]